CN102441109B - 辅助治疗甲亢的中药组合物 - Google Patents
辅助治疗甲亢的中药组合物 Download PDFInfo
- Publication number
- CN102441109B CN102441109B CN2011103921334A CN201110392133A CN102441109B CN 102441109 B CN102441109 B CN 102441109B CN 2011103921334 A CN2011103921334 A CN 2011103921334A CN 201110392133 A CN201110392133 A CN 201110392133A CN 102441109 B CN102441109 B CN 102441109B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- hyperthyroidism
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010020850 Hyperthyroidism Diseases 0.000 title claims abstract description 18
- 239000000203 mixture Substances 0.000 title claims abstract description 14
- 238000009098 adjuvant therapy Methods 0.000 title abstract 2
- 239000009636 Huang Qi Substances 0.000 claims abstract description 6
- 239000003814 drug Substances 0.000 claims description 21
- 229940079593 drug Drugs 0.000 claims description 7
- 210000000582 semen Anatomy 0.000 claims description 7
- 239000009806 pulsatillae Substances 0.000 claims description 5
- 241001523579 Ostrea Species 0.000 claims description 2
- 241000206469 Pulsatilla Species 0.000 claims description 2
- 241000545442 Radix Species 0.000 claims description 2
- 241001530126 Scrophularia Species 0.000 claims description 2
- 239000000463 material Substances 0.000 claims 1
- 229940126680 traditional chinese medicines Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 6
- 208000024891 symptom Diseases 0.000 abstract description 5
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 241001547125 Fritillaria thunbergii Species 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 241000037831 Polygonatum sibiricum Species 0.000 abstract 1
- 240000005809 Prunus persica Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000123887 Pulsatilla chinensis Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 230000000116 mitigating effect Effects 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 229940126673 western medicines Drugs 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010018498 Goitre Diseases 0.000 description 3
- 201000003872 goiter Diseases 0.000 description 3
- 210000001685 thyroid gland Anatomy 0.000 description 3
- 206010020674 Hypermetabolism Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010015993 Eyelid oedema Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- XUIIKFGFIJCVMT-LBPRGKRZSA-N L-thyroxine Chemical compound IC1=CC(C[C@H]([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-LBPRGKRZSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000021642 Muscular disease Diseases 0.000 description 1
- 201000009623 Myopathy Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001936 exophthalmos Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 229950008325 levothyroxine Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- PMRYVIKBURPHAH-UHFFFAOYSA-N methimazole Chemical compound CN1C=CNC1=S PMRYVIKBURPHAH-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229960002178 thiamazole Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种辅助治疗甲亢的中药组合物，其特征在于，采用是由以下重量份数的组分：五味子3-5份，黄精2-4份，黄芪3-4份，柴胡10-13份，白头翁3-6份，泽泻2-5份，牡蛎6-8份，夏枯草1-2份，天冬2-6份，浙贝母2-4份，山栀2-5份，桃仁3-5份，黄药子4-8份，玄参2-4份，青皮1-3份。该方剂合理选用中草药，具有减轻甲亢患者症状，减小西药副作用的特点。
Description
技术领域
本发明涉及一种中药组合物，更具体的是一种具有辅助治疗甲亢的作用的中药组合物。
背景技术
甲状腺机能亢进症简称甲亢，其临床表现为甲状腺功能增强，分泌甲状腺激素(TH)过多，造成机体的神经、循环及消化等系统兴奋性增高和代谢亢进。
由于甲状腺激素过多，作用于全身各个脏器，因而出现的症状多种多样。甲亢多见于女性，男女之比为1∶4～1∶6，年龄各组均可发病，以20～40岁为多见。起病一般缓慢，多数不能确定时日，少数在精神刺激或感染后起病，临床表现轻重不一。表现典型时，高代谢症群、甲状腺肿和眼征三方面的表现均较明显，但如病情较轻可与神经官能症相混淆，有的患者可以某种(些)特殊症状如突眼、恶病质或肌病等为主要表现。老年人和儿童患者的表现常不典型。近年，由于诊断水平逐步提高，轻症和不典型患者的发现已日渐增多。
目前治疗甲亢的常用西药有甲硫咪唑、左甲状腺素、丙基硫尿嘧啶、这些药物能尽快的平衡体内的甲状腺含量，但它们有副作用，比如瘙痒、皮疹、发烧、炎症和白细胞减少，一旦不服用这些药物，往往会复发。
中医将本病归于“瘿瘤”范畴，中医认为，由于七情不遂，肝气郁结，气郁化火，上攻于头，故甲亢患者急躁易怒，面红目赤，口苦咽干，头晕目眩；肝郁化火，灼伤胃阴，胃火炽盛，故消谷善饥；脾气虚弱，运化无权，则消瘦乏力；肝郁气滞，影响冲脉，故月经不调，经少，经闭；肾阴不足，相火妄动，则男子遗精、阳痿；肾阴不足，水不涵木，则肝阳上亢，手舌震颤；心肾阴虚，则心慌、心悸，失眠多梦，多汗；阴虚内热，则怕热，舌质红，脉细数。患者素体阴虚，遇有气郁，则易化火，灼伤阴血。总之，患者气郁化火，炼液为痰，痰气交阻于颈前，则发于瘿肿；痰气凝聚于目，则眼球突出。
因此，本人发明了一种在服用西药的同时，辅助治疗甲亢的中药组合物，具有减轻西药的副作用，提高治疗效果的功效。
发明内容
本发明提供一种辅助治疗甲亢的中药组合物，合理选用中草药，具有减轻甲亢患者症状，减小西药副作用的特点。
本发明采用如下技术方案来实现：
一种辅助治疗甲亢的中药组合物，其特征在于，采用是由以下重量份数的组分：五味子3-5份，黄精2-4份，黄芪3-4份，柴胡10-13份，白头翁3-6份，泽泻2-5份，牡蛎6-8份，夏枯草1-2份，天冬2-6份，浙贝母2-4份，山栀2-5份，桃仁3-5份，黄药子4-8份，玄参2-4份，青皮1-3份。
进一步，本发明的技术方案为：一种辅助治疗甲亢的中药组合物，其特征在于，采用是由以下重量份数的组分：五味子4份，黄精3份，黄芪4份，柴胡12份，白头翁4份，泽泻3份，牡蛎7份，夏枯草1份，天冬5份，浙贝母3份，山栀4份，桃仁4份，黄药子6份，玄参3份，青皮2份。
配制及服用方法：将各原料药的杂质去除，水煎服，一日一剂。十天为一个疗程。
具体实施方式
实施方式一
取五味子3g，黄精2g，黄芪3g，柴胡10g，白头翁3g，泽泻2g，牡蛎6g，夏枯草1g，天冬2g，浙贝母2g，山栀2g，桃仁3g，黄药子4g，玄参2g，青皮1g，将各原料药的杂质去除，水煎服。
实施方式二
取五味子5g，黄精4g，黄芪4g，柴胡13g，白头翁6g，泽泻5g，牡蛎8g，夏枯草2g，天冬6g，浙贝母4g，山栀5g，桃仁5g，黄药子8g，玄参4g，青皮3g，将各原料药的杂质去除，水煎服。
实施方式三
五味子4g，黄精3g，黄芪4g，柴胡12g，白头翁4g，泽泻3g，牡蛎7g，夏枯草1g，天冬5g，浙贝母3g，山栀4g，桃仁4g，黄药子6g，玄参3g，青皮2g，将各原料药的杂质去除，水煎服。
治疗效果
病例一：
黄x，女，43岁，03年查出甲亢，经甲巴唑一年半治疗，现TSH、FT3、FT4在正常范围之内，但甲状腺仍肿大，浑身无力，阵热出汗，脖子涨堵，服用本方剂三个疗程后，症状有明显缓解。
病例二：
张小姐，47岁，已结婚，甲状腺肿外表看不出来，要深按才能摸到，眼珠突出，眼皮水肿，怕光，口干怕热，心悸手抖，服用西药近两年，有所缓和，服用本方剂后，症状减轻。
Claims (2)
1.一种辅助治疗甲亢的中药组合物，其特征在于：采用以下重量份数的中药材组分制成：五味子3-5份，黄精2-4份，黄芪3-4份，柴胡10-13份，白头翁3-6份，泽泻2-5份，牡蛎6-8份，夏枯草1-2份，天冬2-6份，浙贝母2-4份，山栀2-5份，桃仁3-5份，黄药子4-8份，玄参2-4份，青皮1-3份。
2.如权利要求1的一种辅助治疗甲亢的中药组合物，其特征在于：其中所述重量分数的中药材组分如下：五味子4份，黄精3份，黄芪4份，柴胡12份，白头翁4份，泽泻3份，牡蛎7份，夏枯草1份，天冬5份，浙贝母3份，山栀4份，桃仁4份，黄药子6份，玄参3份，青皮2份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103921334A CN102441109B (zh) | 2011-12-01 | 2011-12-01 | 辅助治疗甲亢的中药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011103921334A CN102441109B (zh) | 2011-12-01 | 2011-12-01 | 辅助治疗甲亢的中药组合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102441109A CN102441109A (zh) | 2012-05-09 |
| CN102441109B true CN102441109B (zh) | 2013-07-17 |
Family
ID=46004369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011103921334A Active CN102441109B (zh) | 2011-12-01 | 2011-12-01 | 辅助治疗甲亢的中药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102441109B (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102743548A (zh) * | 2012-07-09 | 2012-10-24 | 姜占义 | 黄药子在制备治疗甲状腺药物中的应用及酊剂 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101028407A (zh) * | 2007-04-04 | 2007-09-05 | 徐向阳 | 一种内服治疗甲亢的中药组合物 |
-
2011
- 2011-12-01 CN CN2011103921334A patent/CN102441109B/zh active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101028407A (zh) * | 2007-04-04 | 2007-09-05 | 徐向阳 | 一种内服治疗甲亢的中药组合物 |
Non-Patent Citations (2)
| Title |
|---|
| 甲状腺机能亢进症的中医药治疗概况;邓小敏;《中国医学文摘 内科学》;20050531;第26卷(第5期);665-667 * |
| 邓小敏.甲状腺机能亢进症的中医药治疗概况.《中国医学文摘 内科学》.2005,第26卷(第5期),665-667. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102441109A (zh) | 2012-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103405728B (zh) | 一种治疗更年期综合症的中药组合物及其制备方法 | |
| CN104288651A (zh) | 一种治疗产后缺乳的药物及其制备方法 | |
| CN102784306A (zh) | 用于治疗仔猪水肿病的中药组合物、饲料和其制备方法 | |
| CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
| CN102973895B (zh) | 一种治疗神经性呕吐的中药组合物 | |
| CN102430105B (zh) | 一种治疗慢性胃炎的中药组合物 | |
| CN102988887A (zh) | 一种治疗卵巢囊肿的中药 | |
| CN102441109B (zh) | 辅助治疗甲亢的中药组合物 | |
| CN103393825B (zh) | 一种治疗紧张型头痛的中药及其制备方法 | |
| CN102416146B (zh) | 一种治疗闭经的中药组合物 | |
| CN102441110B (zh) | 一种辅助治疗甲亢的中药组合物 | |
| CN104721754A (zh) | 一种治疗气滞血瘀型黄褐斑的中药制剂 | |
| CN103690896A (zh) | 一种中药治疗子宫肌瘤的熏方 | |
| CN103191331A (zh) | 用于治疗支气管哮喘缓解期的中药组合物 | |
| CN103550470B (zh) | 儿童健康中药 | |
| CN105169189A (zh) | 一种治疗甲减的药物 | |
| CN103845647A (zh) | 一种治疗脾运失健型小儿厌食的中药 | |
| CN104225376A (zh) | 一种治疗肝胃不和型妊娠恶阻的中药组合物及应用 | |
| CN105477215A (zh) | 一种治疗白内障的中药组合物 | |
| CN104116912A (zh) | 一种用于肿瘤患者放化疗后康复的中药组合物 | |
| CN103463522A (zh) | 一种治疗糖尿病的中药组合物 | |
| CN106266637A (zh) | 一种用于治疗偏头痛的中药组合物 | |
| CN105663657A (zh) | 一种可有效治疗阴虚火旺的汤剂药物及其制备方法 | |
| CN104547331A (zh) | 一种补气养血的药酒的制配方法 | |
| CN103800724A (zh) | 一种治疗甲状腺炎的中药 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Xu Ming Inventor after: Li Jinjin Inventor before: Li Jinjin |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: LI JINJIN TO: XU MING LI JINJIN |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee | ||
| CP02 | Change in the address of a patent holder |
Address after: 364300 Longyan City, Fujian Province Qingyun Wuping County Hill Industrial Park 8 Building No. 2 Patentee after: Li Jinjin Address before: 315300 Zhejiang Province, Cixi city Hushanjiedao Cixi villa villa No. 37 Patentee before: Li Jinjin |
|
| ASS | Succession or assignment of patent right |
Owner name: NANTONG HONGCI PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: LI JINJIN Effective date: 20140609 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 364300 LONGYAN, FUJIAN PROVINCE TO: 226200 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20140609 Address after: 226200 chemical industry park, Nantong, Qidong, Jiangsu Patentee after: NANTONG HONGCI PHARMACEUTICAL CO., LTD. Address before: 364300 Longyan City, Fujian Province Qingyun Wuping County Hill Industrial Park 8 Building No. 2 Patentee before: Li Jinjin |